Type 3 resistant starch prepared from jackfruit alleviated the hyperlipidemia via gut microbiota regulation.
Clicks: 186
ID: 282940
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
186 views
22 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #175 of 200 articles by views in International journal of biological macromolecules
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 200 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Although resistant starch (RS) isolated from raw starch exhibits established regulatory effects on the mouse gut microbiota and associated hyperlipidemia, critical questions persist regarding RS in heated foods - the predominant form in the human diets, namely, the role of RS from heated food in the regulation of hyperlipidemia through gut microbiota is still unclear. This study evaluated the effects of a RS (jackfruit heated resistant starch, JFRS3) from heat-treated jackfruit native starch (JFNS) on hyperlipidemia in golden hamster gut microbes. Compared with JFNS, JFRS3 developed an irregular block-like shape with numerous grooves, exhibited more ordered structures (R: 2.952 and R: 0.964) and greater crystallinity (relative crystallinity (RC): 21.96 %), and transformed into a C-type crystalline structure. Additionally, JFRS3 demonstrated significant antihyperlipidemic effects, which included an increase in high-density lipoprotein cholesterol (HDLC) levels (4.36 mmol/L) and reductions in triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels (14.39, 4.55, and 4.61 mmol/L, respectively), thereby alleviating liver fatty lesions, reducing fat accumulation, and inhibiting adipocyte enlargement. These effects were closely linked to intestinal microbial changes, such as specific microbial enrichment and enhanced gut microbial diversity, potentially influenced by the structural properties of JFRS3. Furthermore, the consumption of JFRS3 was more effective in slowing weight gain and improving blood lipid profiles compared with raw RS present in JFNS. These findings prove that JFRS3 modulates hyperlipidemia induced by a high-fat diet and contributes to the development of alternative strategies for managing high-fat-diet-associated hyperlipidemia.
| Reference Key |
zhang2025type
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhang, Yutong; Liu, Jingyi; Chen, Xiaoai; Xu, Fei; Zhang, Xuan; Zhu, Kexue; Zhang, Jiyue; Zhang, Yanjun |
| Journal | International journal of biological macromolecules |
| Year | 2025 |
| DOI |
10.1016/j.ijbiomac.2025.143452
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.